(29) revealed that claudin-18 is a sensitive and specific marker for adenocarcinomas arising from the gastric and pancreaticobiliary ducts, boasting a sensitivity of 79% and a specificity of 93%. This evidence concerns the gene CLDN18 and adenocarcinoma.